Sciencast Management LP Catalent, Inc. Transaction History

Sciencast Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$87.2 - $114.05 $18,224 - $23,836	-209 Reduced 2.62%	7,775 $884,000
Q1 2022 Apr 26, 2022	BUY	$94.19 - $124.49 $752,012 - $993,928	7,984 New	7,984 $871,000
Q3 2021 Oct 21, 2021	SELL	$109.17 - $142.35 $263,645 - $343,775	-2,415 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$100.34 - $115.69 $242,321 - $279,391	2,415 New	2,415 $272,000
Q2 2019 Aug 08, 2019	SELL	$39.26 - $54.21 $801,885 - $1.11 Million	-20,425 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$29.84 - $43.92 $609,482 - $897,066	20,425 New	20,425 $813,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

Stay updated on Sciencast Management LP with notifications on news.